These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33546754)

  • 61. Transposon mediated reprogramming of buffalo fetal fibroblasts to induced pluripotent stem cells in feeder free culture conditions.
    Kumar D; Anand T; Vijayalakshmy K; Sharma P; Rajendran R; Selokar NL; Yadav PS; Kumar D
    Res Vet Sci; 2019 Apr; 123():252-260. PubMed ID: 30703616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Time-course transcriptome analysis of human cellular reprogramming from multiple cell types reveals the drastic change occurs between the mid phase and the late phase.
    Kuno A; Nishimura K; Takahashi S
    BMC Genomics; 2018 Jan; 19(1):9. PubMed ID: 29298685
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 64. JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process.
    Wang L; Jiang Z; Huang D; Duan J; Huang C; Sullivan S; Vali K; Yin Y; Zhang M; Wegrzyn J; Tian XC; Tang Y
    BMC Genomics; 2018 Mar; 19(1):183. PubMed ID: 29510661
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats.
    Miura K; Oiwa Y; Kawamura Y
    Adv Exp Med Biol; 2021; 1319():329-339. PubMed ID: 34424523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
    Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
    J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells.
    Pini J; Rouleau M; Desnuelle C; Sacconi S; Bendahhou S
    Stem Cells Dev; 2016 Jan; 25(2):151-9. PubMed ID: 26573604
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event.
    Smith ZD; Nachman I; Regev A; Meissner A
    Nat Biotechnol; 2010 May; 28(5):521-6. PubMed ID: 20436460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Common genetic variation drives molecular heterogeneity in human iPSCs.
    Kilpinen H; Goncalves A; Leha A; Afzal V; Alasoo K; Ashford S; Bala S; Bensaddek D; Casale FP; Culley OJ; Danecek P; Faulconbridge A; Harrison PW; Kathuria A; McCarthy D; McCarthy SA; Meleckyte R; Memari Y; Moens N; Soares F; Mann A; Streeter I; Agu CA; Alderton A; Nelson R; Harper S; Patel M; White A; Patel SR; Clarke L; Halai R; Kirton CM; Kolb-Kokocinski A; Beales P; Birney E; Danovi D; Lamond AI; Ouwehand WH; Vallier L; Watt FM; Durbin R; Stegle O; Gaffney DJ
    Nature; 2017 Jun; 546(7658):370-375. PubMed ID: 28489815
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human iPS cell-based therapy: considerations before clinical applications.
    Sun N; Longaker MT; Wu JC
    Cell Cycle; 2010 Mar; 9(5):880-5. PubMed ID: 20160515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Generation of induced pluripotent stem cell Line KAIMRCi001-A by reprogramming erythroid progenitors from peripheral blood of a healthy Saudi donor.
    Al-Shehri M; Baadhaim M; Jamalalddin S; Aboalola D; Daghestani M; AlZahrani H; Malibari D; Mubaraki M; Aldubayan K; AlBalwi M; Alsayegh K
    Stem Cell Res; 2021 Oct; 56():102548. PubMed ID: 34592601
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dendritic cells generated from induced pluripotent stem cells and by direct reprogramming of somatic cells.
    Flosdorf N; Zenke M
    Eur J Immunol; 2022 Dec; 52(12):1880-1888. PubMed ID: 36045608
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reprogramming of Cancer Cells into Induced Pluripotent Stem Cells Questioned.
    Bang JS; Choi NY; Lee M; Ko K; Park YS; Ko K
    Int J Stem Cells; 2019 Nov; 12(3):430-439. PubMed ID: 31474029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lineage tracing of T cell differentiation from T-iPSC by 2D feeder-free culture and 3D organoid culture.
    Ishiguro Y; Iriguchi S; Asano S; Shinohara T; Shiina S; Arima S; Kassai Y; Sakai Y; Obama K; Kaneko S
    Front Immunol; 2023; 14():1303713. PubMed ID: 38162650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficient Induction of Primate iPS Cells Using a Combination of RNA Transfection and Chemical Compounds.
    Watanabe T; Sasaki E
    Methods Mol Biol; 2022; 2454():685-696. PubMed ID: 33772459
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells.
    Yamashita H; Hattori F
    J Vis Exp; 2023 Dec; (202):. PubMed ID: 38108371
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cell reprogramming in a predictable manner on the superhydrophobic microwell array chip.
    Qu J; Wang X; Zhang Y; Hu R; Hao Y; Zhao X; Dong C; Yang C; Zhang W; Sui J; Huang Y; Liu P; Yu J; Chen X; Fan Y
    Biomaterials; 2023 Oct; 301():122215. PubMed ID: 37406601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.